A phase III randomized, controlled study to assess and compare the immunogenicity and tolerability of single and multi-dose vials of Hib-DTP vaccine, a fully liquid quadravalent vaccine and their comparison with TETRAct-Hib vaccine in Indian infants aged 6-14 weeks

Trial Profile

A phase III randomized, controlled study to assess and compare the immunogenicity and tolerability of single and multi-dose vials of Hib-DTP vaccine, a fully liquid quadravalent vaccine and their comparison with TETRAct-Hib vaccine in Indian infants aged 6-14 weeks

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Oct 2011

At a glance

  • Drugs Hib-DTP vaccine (Primary)
  • Indications Diphtheria; Haemophilus infections; Pertussis; Tetanus
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 24 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top